Given our findings of hyperactivated mTOR signaling and susceptibility for pathway inhibition in TTLshort ALL, we next analyzed effects and mechanisms of mTOR inhibition in TTLshort leukemia. This evidence concerns the gene MTOR and acute lymphoblastic leukemia.